Onderneming Macro Group Pharmaceuticals (Macro Capital) S.A.E
Aandelen
MCRO
EGS7D971C011
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,17 EGP | -1,81% | +3,33% | -26,44% |
Vakgebied
Eind 2021 had Macro Group Pharmaceutical S.A.E. (Macro Capital) één productielocatie in Egypte.
Verkoop per activiteit
EGP in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Products, Cosmetics, Sterilizers, Printing Works, and Production of Advertising and Packing and Packaging Materials
100,0
%
| 730 | 100,0 % | 526 | 100,0 % | -27,91% |
Verkoop per regio
EGP in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Egypt
100,0
%
| 730 | 100,0 % | 526 | 100,0 % | -27,91% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hisham Wasfy
CEO | Chief Executive Officer | - | 01-12-19 |
Ashraf Hamdy
DFI | Director of Finance/CFO | - | 01-07-19 |
Zeina Shahin
IRC | Investor Relations Contact | - | - |
Tamer Raouf
SAM | Sales & Marketing | - | 01-01-22 |
Mahmoud El Nayeb
PRN | Corporate Officer/Principal | - | - |
Sherine Mostafa
HRO | Human Resources Officer | - | - |
Mohamed Yakout
PRN | Corporate Officer/Principal | - | - |
Mohamed Azzazy
SAM | Sales & Marketing | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sahar El-Sallab
BRD | Director/Board Member | - | 01-01-21 |
Ahmed Badreldin
BRD | Director/Board Member | 52 | 01-01-21 |
Ahmed El-Nayeb
FOU | Founder | - | 01-01-02 |
Director/Board Member | 36 | 01-01-21 | |
Conor Mcnaughton
BRD | Director/Board Member | 44 | 01-01-21 |
Ahmed Rady
BRD | Director/Board Member | - | 01-03-18 |
Hisham Wasfy
CEO | Chief Executive Officer | - | 01-12-19 |
Tamir Saeed
BRD | Director/Board Member | - | 01-01-21 |
Norbert Lurz
BRD | Director/Board Member | - | 01-01-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 570 206 455 | 154 098 266 ( 27,02 %) | 8 100 000 ( 1,421 %) | 27,02 % |
Bedrijfsgegevens
Macro Group Pharmaceutical SAE
83, Al Moltaka Al Arabi Tower 2 & 3
, Sheraton
+
http://www.macro-egy.comSector
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-26,44% | 25,78 mln. | |
+30,38% | 684 mld. | |
+26,51% | 568 mld. | |
-4,36% | 361 mld. | |
+19,30% | 329 mld. | |
+3,73% | 284 mld. | |
+16,70% | 240 mld. | |
+8,78% | 208 mld. | |
-7,93% | 200 mld. | |
+7,68% | 166 mld. |
- Beurs
- Aandelen
- Koers MCRO
- Onderneming Macro Group Pharmaceuticals (Macro Capital) S.A.E